Article Information
History
- October 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Farha Bary#,1,†,
- Maneshka Vindesh Karunananda#,1,†,
- Chandima Jeewandara#,1,†,
- Saubhagya Danasekara#,1,†,
- Dinuka Guruge2,
- Rizna Rizan1,
- Inoka Sepali Aberathna1,
- Thushali Ranasinghe1,
- Heshan Kuruppu1,
- Jeewantha Jayamali1,
- Lahiru Perera1,
- Harshani Chathurangika1,
- Amaya Gunaratne1,
- Naduni Dasanthi1,
- Chathura Ranatunga1,
- A.W. Shashini Ishara1,
- Sathsara Yatiwelle1,
- Ruwan Wijayamuni2,
- Tiong Kit Tan3,4,
- Alain Townsend3,4,
- Graham S. Ogg3,4 and
- Gathsaurie Neelika Malavige1,3,*
- 1Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
- 2Colombo Municipal Council, Colombo, Sri Lanka
- 3MRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
- 4Centre for Translational Immunology, Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, United Kingdom
- ↵*Correspondence should be addressed to: Prof. Neelika Malavige DPhil (Oxon), FRCP (Lond), FRCPath (UK), Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Sri Lanka. Tel +94 (0) 772443193; Email: gathsaurie.malavige{at}ndm.ox.ac.uk
↵† Contributed equally
Posted October 04, 2024.
Changes in population immunity to omicron SARS-CoV-2 variants and selected Sarbecoviruses from 2020 to 2023 in urban Colombo, Sri Lanka
